Published in J Cereb Blood Flow Metab on December 01, 2001
Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience (2008) 2.55
Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal (2011) 1.96
Cortical spreading depression activates and upregulates MMP-9. J Clin Invest (2004) 1.93
Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis (2010) 1.90
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci (2006) 1.58
Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab (2009) 1.52
Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab (2013) 1.41
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res (2009) 1.38
Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma (2008) 1.35
Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther (2007) 1.29
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem (2008) 1.24
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab (2009) 1.23
Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol (2013) 1.23
Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab (2008) 1.18
Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. J Neurochem (2009) 1.15
The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol (2008) 1.11
Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo. J Cereb Blood Flow Metab (2010) 1.11
Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation (2011) 1.05
Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab (2015) 1.03
HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J Neuropathol Exp Neurol (2010) 1.03
Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front Neurosci (2015) 1.02
Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons. Neuroscience (2012) 1.01
Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol (2007) 1.00
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats. Exp Neurol (2008) 1.00
Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. ScientificWorldJournal (2012) 0.97
Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions. Prog Neurobiol (2012) 0.97
Matrix metalloproteinases as therapeutic targets for stroke. Brain Res (2015) 0.97
Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res (2007) 0.96
Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit (2011) 0.93
Blood-brain barrier dysfunction in disorders of the developing brain. Front Neurosci (2015) 0.92
Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Stroke (2010) 0.90
Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia. J Mol Neurosci (2012) 0.90
Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol Ther (Seoul) (2012) 0.89
Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? Neural Plast (2015) 0.88
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem (2010) 0.88
Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci (2015) 0.88
Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers. Brain Res (2008) 0.88
Effect of chronic alcohol consumption on brain damage following transient focal ischemia. Brain Res (2007) 0.86
Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci (2010) 0.86
AM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia. Br J Pharmacol (2006) 0.86
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation (2013) 0.85
Selective vulnerability of synaptic signaling and metabolism to nitrosative stress. Antioxid Redox Signal (2012) 0.85
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol (2011) 0.84
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases. Mar Drugs (2015) 0.82
Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. Int J Mol Sci (2011) 0.81
Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro. PLoS One (2015) 0.81
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke. Front Cell Neurosci (2016) 0.81
Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke. Circ Res (2017) 0.80
Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets. J Neurol Neurophysiol (2011) 0.79
Increased expression of EMMPRIN and VEGF in the rat brain after gamma irradiation. J Korean Med Sci (2012) 0.79
Hemostasis and alterations of the central nervous system. Semin Thromb Hemost (2013) 0.79
Ethanol Extract of Bupleurum falcatum Improves Functional Recovery by Inhibiting Matrix Metalloproteinases-2 and -9 Activation and Inflammation after Spinal Cord Injury. Exp Neurobiol (2010) 0.78
Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism. Stroke Res Treat (2014) 0.78
Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis. Mol Neurobiol (2016) 0.76
Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3. Mol Neurobiol (2016) 0.76
Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nat Commun (2015) 0.76
The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier. J Neuropathol Exp Neurol (2008) 0.76
Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes. Antioxidants (Basel) (2014) 0.76
Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke. Toxicol Res (2013) 0.76
Matrix metalloproteinases in cerebral ischemia. J Clin Neurol (2006) 0.75
Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxid Med Cell Longev (2016) 0.75
Effects of hyperbaric oxygen on the expression of claudins after cerebral ischemia-reperfusion in rats. Exp Brain Res (2011) 0.75
Morroniside improves microvascular functional integrity of the neurovascular unit after cerebral ischemia. PLoS One (2014) 0.75
The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases. Biomed Res Int (2016) 0.75
Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation. J Radiat Res (2012) 0.75
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants? Arch Dis Child Fetal Neonatal Ed (2004) 0.75
Role of ATP as a Key Signaling Molecule Mediating Radiation-Induced Biological Effects. Dose Response (2017) 0.75
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment. Int J Mol Sci (2016) 0.75
Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke. Oxid Med Cell Longev (2016) 0.75
Nuclear matrix metalloproteinases: functions resemble the evolution from the intracellular to the extracellular compartment. Cell Death Discov (2017) 0.75
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 7.17
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med (2000) 6.27
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A (1999) 3.96
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29
Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun (1991) 2.52
Free radical pathways in CNS injury. J Neurotrauma (2000) 2.52
Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39
Chloroplast DNA codes for the primary structure of the large subunit of fraction I protein. Biochim Biophys Acta (1972) 2.34
P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci (2000) 2.23
Crystalline fraction I protein: preparation in large yield. Science (1972) 2.09
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med (1996) 2.08
Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Br J Cancer (2007) 2.00
Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J (2000) 1.99
Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke (1994) 1.99
Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab (1999) 1.87
Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci (1997) 1.84
Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2001) 1.83
Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A (1991) 1.82
Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res (1999) 1.62
Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med (1997) 1.60
Child care practices and cot death in Hong Kong. N Z Med J (1996) 1.60
Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (1997) 1.58
Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs. Clin Exp Allergy (2005) 1.56
Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet (1997) 1.56
Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci (1999) 1.56
A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest (2000) 1.54
Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A (1996) 1.50
Acute eosinophilic pneumonia caused by cigarette smoking. Intern Med (2000) 1.49
Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg (1998) 1.45
The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol (1993) 1.44
In vivo airway eosinophil accumulation induced by polymyxin-B reduces bronchial responsiveness in guinea pigs. Clin Exp Allergy (2001) 1.41
Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys (1997) 1.40
Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci (1999) 1.39
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke (1999) 1.37
Clinical events relating to intraventricular haemorrhage in the newborn. Arch Dis Child (1979) 1.37
Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem (2001) 1.35
Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol (1988) 1.35
Identification of two loci for resistance to clubroot (Plasmodiophora brassicae Woronin) in Brassica rapa L. Theor Appl Genet (2003) 1.34
The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci (2000) 1.34
Histochemical localization of nitric oxide synthase in rat enteric nervous system. Neuroscience (1993) 1.32
CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+]i, and insulin secretion. J Biol Chem (1999) 1.31
Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer (1996) 1.29
Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity (2001) 1.29
Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages. Br J Pharmacol (1988) 1.28
Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur J Immunol (1998) 1.27
Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol (1998) 1.26
Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest (1997) 1.26
Kinetics of disulfide bond reduction in alpha-lactalbumin by dithiothreitol and molecular basis of superreactivity of the Cys6-Cys120 disulfide bond. Biochemistry (1990) 1.23
Timing of intraventricular haemorrhage. Arch Dis Child (1977) 1.22
Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (1998) 1.21
Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke (1999) 1.21
Cloning and sequencing of a 36-kb region of the Bacillus subtilis genome between the gnt and iol operons. DNA Res (1995) 1.20
Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax (2002) 1.19
Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology (1984) 1.18
Response of postmitotic neurons to X-irradiation: implications for the role of DNA damage in neuronal apoptosis. J Neurosci (1998) 1.17
The leptomeningeal "ivy sign" on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol (2009) 1.16
SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab (2001) 1.16
The crystal structure of human cathepsin L complexed with E-64. FEBS Lett (1997) 1.15
Endoscopic thyroid resection using cutaneous elevation in lieu of insufflation. Surg Endosc (2001) 1.15
A novel strain sensor based on the campaniform sensillum of insects. Philos Trans A Math Phys Eng Sci (2002) 1.15
Characterization of mutations in the two-component histidine kinase gene that confer fludioxonil resistance and osmotic sensitivity in the os-1 mutants of Neurospora crassa. Pest Manag Sci (2001) 1.15
Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem Cell Biol (1999) 1.15
Carotenoids affect proliferation of human prostate cancer cells. J Nutr (2001) 1.13
Sequencing of a 65 kb region of the Bacillus subtilis genome containing the lic and cel loci, and creation of a 177 kb contig covering the gnt-sacXY region. Microbiology (1996) 1.10
Phospholipid degradation and edema development in cold-injured rat brain. Brain Res (1983) 1.10
Induction of 70-kDa heat shock protein and hsp70 mRNA following transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1993) 1.10
Determination of a 17,484 bp nucleotide sequence around the 39 degrees region of the Bacillus subtilis chromosome and similarity analysis of the products of putative ORFs. Microbiology (1995) 1.08
Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol (1998) 1.08
Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+,K(+)-ATPase activity. J Cereb Blood Flow Metab (1994) 1.07
T-->A transversion 11 bp from a splice acceptor site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. Hum Mol Genet (1995) 1.07
Induction of brain edema following intracerebral injection of arachidonic acid. Ann Neurol (1983) 1.07
Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J Interferon Cytokine Res (2001) 1.07
Allergic granulomatosis and angiitis (Churg-Strauss syndrome) presenting as acute acalculous cholecystitis. J Rheumatol (1990) 1.06
A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. Biochem Biophys Res Commun (1993) 1.06
Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.06
The role of arachidonic acid in vasogenic brain edema. Fed Proc (1984) 1.05
Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. Stroke (2001) 1.05
Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg (1996) 1.04
Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res (1998) 1.04
Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol (1987) 1.03
Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol (1997) 1.03
Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg (1993) 1.03
Identification and characterization of a new gene physically linked to the ATM gene. Genome Res (1996) 1.02
Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA. Eur J Pediatr (1988) 1.02
Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem Soc Trans (2006) 1.02
Localization of NADPH-diaphorase-containing neurons in sensory ganglia of the rat. J Comp Neurol (1991) 1.02
A prospective, randomized, double-blind, controlled trial on the efficacy of carbon dioxide insufflation in gastric endoscopic submucosal dissection. Endoscopy (2013) 1.02
A pilot study to assess mediastinal emphysema after esophageal endoscopic submucosal dissection with carbon dioxide insufflation. Endoscopy (2012) 1.02
Comparative studies on the properties of tryptophanase and tyrosine phenol-lyase immobilized directly on Sepharose or by use of Sepharose-bound pyridoxal 5'-phosphate. Eur J Biochem (1975) 1.01
Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab (1999) 1.01